05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
The North Carolina Court of Appeals recently determined that a builder who fails to comply with stat...
Read More >
Recognizing that Japan has entered a new phase in its fight against the spread of Coronavirus Diseas...
Read More >
In September, the Treasury Department issued final regulations governing hardship withdrawals from 4...
Read More >
On August 29, 2019, legislators from the Michigan House of Representatives announced an ambitious pa...
Read More >
The U.S. Department of Labor has proposed a new rule to allow employers who do not take a tip credit...
Read More >
Soft Deadline for Wage/Hour Data Submission? September 30, 2019, was the deadline for employers to s...
Read More >